Searched for
JANSSEN BIOTECH
Covaxin gets WHO approval for emergency use listingWHO's TAG is an independent advisory group that provides recommendations to the WHO on whether a Covid 19 vaccine can be listed for emergen...03 Nov, 2021, 07.03 PM IST- Bharat Biotech's Covaxin gets WHO okay for emergency useHyderabad-based Bharat Biotech, which has developed Covaxin, submitted EOI (Expression of Interest) to the WHO on April 19 for the vaccine'...03 Nov, 2021, 06.46 PM IST
- Bharat Biotech submits additional data to WHOIn its meeting on October 26, the TAG had sought "additional clarification" from Bharat Biotech to conduct a final risk-benefit assessment ...02 Nov, 2021, 07.40 AM IST
- We trust Indian industry, Bharat Biotech has been submitting data regularly, very quickly: WHO official on Covaxin EULBharat Biotech's Covaxin and AstraZeneca and Oxford University's Covishield are the two widely used vaccines in India.28 Oct, 2021, 09.48 PM IST
- WHO seeks 'additional clarifications' from Bharat Biotech for Covaxin to conduct final 'risk-benefit assessment'"The TAG met today (26 October 2021) and decided that additional clarifications from the manufacturer are needed to conduct a final EUL ris...27 Oct, 2021, 02.38 PM IST
- Technical Advisory Group seeks additional clarification on Covaxin for Emergency Use ListingWhile the WHO has so far approved Covid-19 vaccines of Pfizer-BioNTech, AstraZeneca-SK Bio/Serum Institute of India, Johnson & Johnson-Jans...27 Oct, 2021, 10.15 AM IST
- Review of Covaxin by WHO underway; expect a recommendation within 24 hours: spokesperson"On COVAXIN, the technical advisory group that reviews all the data for a potential emergency use listing are indeed reviewing that data to...26 Oct, 2021, 10.10 PM IST
- WHO's advisory group set to meet on October 26 to decide on Covaxin EUL approvalWhile the WHO has so far approved Covid-19 vaccines of Pfizer-BioNTech, AstraZeneca-SK Bio/Serum Institute of India, Johnson & Johnson-Jans...25 Oct, 2021, 07.35 AM IST
- WHO may take a call on Covaxin todayThe company said last week that it was diligently working with the WHO to obtain Emergency Use Listing (EUL) at the earliest adding it is n...05 Oct, 2021, 10.36 AM IST
- WHO to decide on Bharat Biotech's Covaxin clearance in OctoberSoumya Swaminathan, WHO's chief scientist, told ET that the "process is ongoing".30 Sep, 2021, 12.25 PM IST
- WHO to review Covaxin; emergency use approval may come by mid-SeptemberThe WHO global advisory committee on vaccine safety will assess immunogenicity, vaccine safety and vaccine effectiveness of Covaxin, a cruc...02 Sep, 2021, 10.12 AM IST
- Approvals for J&J jabs soon, pricing to be reasonable: Vaccine Task Force co-chair K Vijay RaghavanGlobal vaccine maker Johnson and Johnson has applied to India’s drug regulator seeking permission to conduct phase 3 clinical trial of its ...20 Apr, 2021, 03.24 PM IST
- Johnson & Johnson set to begin India trial of its single-shot vaccine, says reportThe U.S. drugs and healthcare giant's vaccine is currently approved for use in the United States, the European Union and other nations incl...09 Apr, 2021, 02.57 PM IST
- Johnson & Johnson requests emergency authorization for Covid vaccineJ&J subsidiary Janssen Biotech "has submitted an application to the US Food and Drug Administration (FDA) requesting Emergency Use Authoriz...05 Feb, 2021, 08.54 AM IST
- UK government strikes 90 million dose deal for two potential COVID-19 vaccine candidatesIf the vaccines are found safe and successful in clinical trials, both could be delivered to the UK in mid-2021 and would be given first to...14 Aug, 2020, 06.48 PM IST
- Glenmark Pharma gets USFDA nod for prostate cancer treatment drugShares of Glenmark Pharma were trading 0.15 per cent higher at Rs 286.00 apiece on the BSE.17 Oct, 2019, 03.41 PM IST
- Genmab inks $1.1 bn deal with Johnson & JohnsonDanish pharma firm Genmab has said that it had reached a deal worth up to $1.1 bn with US drug giant Johnson & Johnson.30 Aug, 2012, 03.43 PM IST
Load More
